meta_pixel
Tapesearch Logo
Log in
This Week in Cardiology

Apr 15, 2022 This Week in Cardiology

This Week in Cardiology

Medscape Podcasts

Medicine, Science, Health & Fitness

4.9963 Ratings

🗓️ 15 April 2022

⏱️ 25 minutes

🧾️ Download transcript

Summary

ACC Recap, Part 2: VT ablation, HF care, three-vessel disease, and patiromer are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I – VT ablation

VT Ablation After First ICD Shock Boosts Survival: PARTITA

https://www.medscape.com/viewarticle/971969

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.122.059598

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia https://www.jacc.org/doi/10.1016/j.jacc.2022.01.050

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs https://www.nejm.org/doi/full/10.1056/NEJMoa1513614

II – HF Care

Alerts Improve Prescribing of HF Quadruple Therapy: PROMPT-HF https://www.medscape.com/viewarticle/972079

Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial https://www.jacc.org/doi/10.1016/j.jacc.2022.03.338

Reassessing Quality Assessment — The Flawed System for Fixing a Flawed System https://www.nejm.org/doi/full/10.1056/NEJMms2200976

III – Three-Vessel Disease

FAME 3 Subanalysis Adds Twist to Negative Primary Results

https://www.medscape.com/viewarticle/971495

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery https://www.nejm.org/doi/10.1056/NEJMoa2112299

Quality of Life After Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.122.060049

IV – Treating Drug Side Effects with More Drugs

DIAMOND: Adding Patiromer Helps Optimize HF Meds, Foils Hyperkalemia https://www.medscape.com/viewarticle/971616

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact

news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0

You're listening to this week in cardiology from the heart

0:03.4

org medscape cardiology this podcast is intended for health care

0:07.6

professionals only any views expressed are the presenters own and do not

0:11.2

necessarily reflect the views of WebMD or Medscape.

0:15.1

You can now access the latest in medical news on your Amazon Alexa-enabled device.

0:19.7

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I highlight the top

0:24.7

medical stories of the day.

0:26.5

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical Minute on Amazon

0:31.3

and click enable or open the Amazon Alexa app go to skills

0:34.7

search for Medscape Medical Minute and click enable then say Alexa what's the

0:40.1

news or Alexa what's my flash briefing I hope you'll join us.

0:44.0

Hi everyone this is John Mandrola from the heart dot org medscape cardiology and this

0:49.8

is this week in cardiology more from the ACC, ventricular attacker cardioblation, heart failure,

1:01.1

triple vessel coronary disease, and a doozy.

1:06.0

So two small randomized controlled trials published recently

1:09.4

got the EP community excited about quote unquote early VT Ablation. Both of these

1:17.1

trials had top-line positive results but while I love RCTs and I wish medicine did more of them, these two studies should not change our

1:26.8

cautious approach to VT Ablation. There are just too many limitations in these papers.

1:35.7

As background background I'm going to discuss VT Ablation in patients with substantial structural heart disease which is

1:39.7

usually is schemic. This differs a lot from oblating VT in normal hearts. is

1:45.0

a systemic. This differs a lot from a blading VT in normal hearts, which is less risky and often curative,

1:48.0

similar to SVT.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.